Current recommendations of chemotherapy and pharmacology of antituberculosis drugs.
Due to presence of natural mutant bacilli, existence of the bacilli in several populations and in various sites, combination of two, three or more drugs is necessary to treat tuberculosis and that too for a long time. Inadequate therapy leads to relapse and treatment failure. The cumulative effect of negligence, mistakes and new threats (e.g., HIV infection) has made the treatment difficult today. The National Tuberculosis Control Programme of 1962 has been modified recently by Revised National Tuberculosis Control Programme. The targets are to detect at least 70% of new smear positive cases and to achieve at least 85% cure rate by Directly Observed Therapy Short course (DOTS). Categorisation of patients and treatment recommendations are discussed along with pharmacology of antituberculosis drugs.
Bhattacharyya
P
P
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy; D000995:Antitubercular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006801:Humans; D007194:India; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000995:Antitubercular Agents